gilberto lopes ✓

@GlopesMd · Miami, FL · joined 16 Nov 2013

Chief MedOnc @SylvesterCancer @UnivMiami. Improving access to cancer meds in LMICs. Editor-in-Chief emeritus JCO GO, Board Member @UICC - chair #ATOMcoalition

37 564Followers

40 000Following

57 608Posts total

10.7KViews on collected posts

Neueste Beiträge

gilberto lopes ✓@GlopesMd8 Sep

Visual summary of today’s phase 3 DeLLphi-305 update in ES-SCLC: tarlatamab + durvalumab maintenance improved OS vs durvalumab alone after induction durvalumab + platinum/etoposide. PFS and ORR also positive. Full data still needed. #SCLC #LCSM https://t.co/pyeQbPyoRc

1K views · 15 likes · 7 reposts · 1 replies Open on X →

gilberto lopes ✓@GlopesMd8 Sep

1/3 Big news in #SCLC today. Phase III DeLLphi-305: tarlatamab + durvalumab maintenance improved OS vs durvalumab alone after first-line platinum/etoposide + durvalumab in ES-SCLC. PFS and ORR also positive. Very encouraging—full data will matter. 1K views · 13 likes · 3 reposts · 2 replies Open on X →

gilberto lopes ✓@GlopesMd8 Sep

@iaslc #WCLC26 @oncoalert @oncodaily @larvol @tribeMDUS @sylvestercancer @oncbrothers @chinmay @Jani_Chinmay @latinamd @colazagasti @openmedicineHQ @asco @myesmo @openmedkate @openmedben @chadinabhan 760 views · 6 likes · 2 reposts · 0 replies Open on X →

gilberto lopes ✓@GlopesMd8 Sep

Seoul, Rebuilt: What a City and the World Conference on Lung Cancer Can Teach Us About Progress https://t.co/b6TNHeXEOV @IASLC #WCLC26 @uicc 1.8K views · 19 likes · 6 reposts · 1 replies Open on X →

gilberto lopes ✓@GlopesMd20 Aug

@GlopesMd @WSJopinion Really nice piece my friend 👌🏻👍🏻 31 views · 1 likes · 0 reposts · 0 replies Open on X →

gilberto lopes ✓@GlopesMd6 Aug

@GlopesMd @WSJopinion well said 172 views · 1 likes · 1 reposts · 1 replies Open on X →

gilberto lopes ✓@GlopesMd6 Aug

“Americans grew richer in the goods that markets could freely supply, and poorer in the three purchases that define middle-class standing: a house, a degree and a doctor.” 2.5K views · 7 likes · 3 reposts · 0 replies Open on X →

gilberto lopes ✓@GlopesMd5 Aug

My piece @WSJopinion: Americans Got Wealthier but Don’t Feel Like It https://t.co/QiKHd2XY1Y https://t.co/HZNwsDLl8y

3.4K views · 8 likes · 3 reposts · 2 replies Open on X →

Im Vergleich zu Konten gleicher Größe

8 Beiträge aus den letzten 90 Tagen, verglichen mit der Größenklasse 10K–100K Follower. genau im Median seiner Follower-Klasse.

Medianaufrufe1 025dieses Konto924Median für 10K–100K

Reichweite, %2.73%dieses Konto3.62%Median für 10K–100K

Interaktion, %1.63%dieses Konto1.52%Median für 10K–100K

Kennzahl	Dieses Konto	Median für 10K–100K	Verhältnis
Medianaufrufe pro Beitrag	1 025	924	1.11×
Reichweite (Aufrufe ÷ Follower)	2.73%	3.62%	0.75×
Interaktionsrate	1.63%	1.52%	1.07×

Weitere Konten dieser Größe → Mit einem anderen Konto vergleichen → Wie diese Vergleichswerte entstehen →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3.4K5 Aug

2.5K6 Aug

172

3120 Aug

1.8K8 Sep

760

Last 8 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.41%5 Aug

0.41%6 Aug

1.74%

3.23%20 Aug

1.51%8 Sep

1.05%

1.77%

2.22%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes63.1%70 in total

Reposts22.5%25 in total

Replies6.3%7 in total

Quotes1.8%2 in total

Bookmarks6.3%7 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Neueste Beiträge

Im Vergleich zu Konten gleicher Größe

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Ähnliche Konten